| Control group (n = 364) | hCG group (n = 337) |
---|---|---|
IVF/ICSI cycles: | ||
 Age at index IVF/ICSI (years) | 31.4 ± 4.8 | 31.7 ± 4.7 |
 Duration of subfertility (years) | 4.5 ± 3.2 | 4.4 ± 3.1 |
 Body mass index (kg/m2) | 21.4 ± 2.9 | 21.5 ± 3.1 |
 Primary subfertility | 169/364 (46.4%) | 141/337 (41.8%) |
Number of previous ET cycles | 1 (0–1) | 0 (0–1) |
Primary diagnosis | ||
Tubal | 123/364 (33.8%) | 111/337 (32.9%) |
 Uterine | 5/364 (1.4%) | 4/337 (1.2%) |
 Anovulation | 8/364 (2.2%) | 14/337 (4.2%) |
 Diminished ovarian reserve | 8/364 (2.2%) | 7/337 (2.1%) |
 Mixed factors of female | 70/364 (19.2%) | 77/337 (22.8%) |
 Male | 36/364 (9.9%) | 30/337 (8.9%) |
 Both husband and wife | 109/364 (29.9%) | 86/337 (25.5%) |
 Unexplained | 5/364 (1.4%) | 8/337 (2.4%) |
Number of oocytes retrieved | 14.5 ± 7.9 | 15.6 ± 8.5 |
Number of mature oocytes | 12.5 ± 7.0 | 13.4 ± 7.3 |
FET cycles: | ||
 Maternal age at FET (years) | 32.2 ± 5.2 | 32.5 ± 4.6 |
 First ET cycle | 191/364 (52.5%) | 178/337 (52.8%) |
 Endometrial thickness (mm) | 9.8 ± 2.0 | 9.8 ± 1.6 |
 Duration of estradiol administration (days) | 14.2 ± 2.9 | 14.5 ± 2.9 |
 P levels (ng/mL) * | 0.5 ± 0.2 | 0.4 ± 0.2 |
 E2 levels (pg/mL) | 253.3 (175.7–400.7) | 253.6 (179.5–544.2) |
 Number of embryos transferred | 2 (2–2) | 2 (2–2) |
 Number of good-quality embryos | 2 (1–2) | 2 (1–2) |
 Single embryo FET cycles | 50/364 (13.7%) | 50/337 (14.8%) |
 Single cleavage-stage embryo | 18/272 (6.6%) | 18/252 (7.1%) |
 Single blastocyst | 32/83 (38.6%) | 32/81 (39.5%) |
Stage of embryo transferred | ||
 Cleavage stage | 272/364 (74.7%) | 252/337 (74.8%) |
 Blastocyst stage | 83/364 (22.8%) | 81/337 (24.0%) |
 Both stage | 9/364 (2.5%) | 4/337 (1.2%) |